Clues to Why a Breakthrough Pancreatic Cancer Drug Eventually Stops Working

Več na: https://www.nytimes.com/2026/09/30/science/pancreatic-cancer-drug-daraxonrasib-ben-sasse-resistance.html

nazaj


Vse znamke, logotipi in slike so zaščitene in so last lastnikov oz. družb. Vse pravice pridržane. © 1998-2023 Aguatera d.o.o.